Breakthrough Nucleic Acid Therapeutics by QTsomeTM Technology.
Advances in medical technology and our understanding of biology have paved the way for the treatment diseases once thought incurable. Delivery of drug to the correct site of therapeutic action while minimizing off-target exposure is paramount to achieving safe and effective therapy. WGI overcomes delivery challenges in complex diseases including oncology through strategic application of nanotechnology.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 1629 K St Nw, Washington,district Of Columbia 20006,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- thewogroup.com
- HQ
- Washington, District of Columbia
The Whiteoak Group, Inc. Questions
The Whiteoak Group, Inc.'s website is thewogroup.com
The Whiteoak Group, Inc.'s LinkedIn profile is https://www.linkedin.com/company/the-whiteoak-group-llc
The Whiteoak Group, Inc. has
16 employees.
View email and phone details for 16
employees at The Whiteoak Group, Inc..
The Whiteoak Group, Inc.'s industry is
Biotechnology Research
The Whiteoak Group, Inc.'s top competitors are
Biobridge Global,
Zhejiang Haichang Biotech,
Innostar,
Hansoh Bio,
Enqubio Inc.,
Angitia Biopharmaceuticals,
Nera,
Calibre Cpa Group, Pllc,
Adlai Nortye,
Lantheus.
The Whiteoak Group, Inc.'s categories are Biotechnology Research
The Whiteoak Group, Inc.'s founding year is 2014
